Moreover, amplifications of the Met locus and Met overexpression occur in Brca1/p53-deficient mouse tumors, a model of basal-like breast cancers (Smolen et al., 2006; Gastaldi et al., 2013). Here, TP53 is linked to breast carcinoma.